Sido Muncul PT
PT Industri Jamu Dan Farmasi Sido Muncul Tbk. is Indonesia's largest herbal medicine manufacturer, producing traditional jamu, supplements, and functional beverages (Tolak Angin, KukuBima Ener-G!, Sido Muncul C-1000, Sari Kunyit) for mass-market Indonesian consumers through nationwide retail distribution and selected international exports since 1951.
- Company typePublic
- Founded1951
- HeadquartersSemarang, Indonesia
- Headcount1,001–5,000
- GTM typeB2C
- OfferingHardware or Manufacturing
What Sido Muncul PT does
PT Industri Jamu Dan Farmasi Sido Muncul Tbk. (Sido Muncul) is Indonesia's largest herbal medicine manufacturer, in operation since 1951 and incorporated under current form in 1975. The company develops, manufactures, and markets a portfolio centered on traditional jamu, ready-to-drink and powdered beverages, dietary supplements, and modern herbal pharmaceuticals. Core brands include Tolak Angin (herbal remedy for masuk angin symptoms, in market since 1930), KukuBima Ener-G! C1000, Sido Muncul C-1000, Sari Kunyit Soft Capsule, Susu Jahe, Kopi Jahe, Tolak Linu, with recent extensions including Tolak Angin Batuk (2024), Tentrem White Coffee (2023), and Alang Sari Cool RTD (2022). All products carry BPOM distribution authorization and MUI halal certification. Manufacturing runs across seven specialized facilities in Semarang (extraction, modern herbal, traditional jamu, powdered drinks, RTD, supplements, pharmaceuticals), supported by an ISO 17025-certified raw-materials testing laboratory and combined monthly production capacity of approximately 100 million sachets.
The company executes a sales-led, multi-tiered Indonesian distribution strategy through wholly-owned PT Muncul Mekar and a network of wholesalers, supermarkets, agents, small shops and retailers; in April 2024 a sub-distributor agreement was signed with PT Atri Distribusindo. B2B supplier engagement runs through an e-Procurement platform, while direct-to-consumer sales flow via the Sidomuncul Store e-commerce site. The company has selectively internationalized, dispatching its first Tolak Angin shipment to Saudi Arabia in August 2020, exporting essential oils to France in November 2021, and operating a wholly-owned Nigerian subsidiary (Muncul Nigeria Limited).
Sido Muncul is publicly listed on the Indonesia Stock Exchange (IDX: SIDO). It has historically maintained dividend payout ratios above 90% since IPO, distributing Rp 540 billion in dividends in May 2024. Private equity firm Affinity Equity Partners held a strategic stake via PT Hotel Candi Baru from February 2021 until concluding its partnership in April 2024. Founding family members including Irwan Hidayat, Sofjan Hidayat, and David Hidayat (President Director) remain active in senior leadership and board positions. The company is headquartered in Semarang with a Jakarta branch office, employs 1,001-5,000 staff, and has received multiple recognitions including PROPER Emas (2020, 2023), ASEAN Corporate Governance Scorecard award (2021), and Steward Leadership 25 (2023).
Sido Muncul PT firmographics
Firmographics- Name
- Sido Muncul PT
- Legal name
- PT Industri Jamu Dan Farmasi Sido Muncul Tbk.
- Website
- https://sidomuncul.co.id
- Company type
- Public
- Founded year
- 1951
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- PT Industri Jamu Dan Farmasi Sido Muncul Tbk. is Indonesia's largest herbal medicine manufacturer, producing traditional jamu, supplements, and functional beverages (Tolak Angin, KukuBima Ener-G!, Sido Muncul C-1000, Sari Kunyit) for mass-market Indonesian consumers through nationwide retail distribution and selected international exports since 1951.
- Ownership category
- akta.pro rank
Sido Muncul PT industry classification
Industry- Product category
- Herbal Pharmaceuticals
- NAICS
- Soft Drink Manufacturing (312111), Food (Health) Supplement Retailers (456191), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Beverages (2080), Food And Kindred Products (2000)
- akta.pro primary industry
- Herbal & Botanical Supplements (CRADAGAD)
- akta.pro secondary industries
- Vitamins & Minerals (Single Nutrients) (CRADAGAB), Multivitamins & Daily Packs (CRADAGAC), Natural Extracts & Botanical Concentrates for Beverages (herbal, spice, aromatic extracts) (AFAFAGAJ), Powdered & Instant Beverage Mixes (Drink Mixes, Instant Coffee/Tea, Electrolytes) (CRADAHAN)
Keywords
Where Sido Muncul PT is headquartered
LocationHeadquarters
- HQ city
- Semarang
- HQ country
- Indonesia
- HQ region
- Asia
Offices3 records
Markets served
Sido Muncul PT business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Herbal Medicine Products: Traditional herbal medicine (jamu) products including Tolak Angin, Tolak Linu, Sari Kunyit, and other herbal remedies sold through retail channels
- Beverage Products: Ready-to-drink and powdered beverage products including Susu Jahe, Kopi Jahe, KukuBima Ener-G!, Vitamin C-1000, and RTD vitamin products
- Nutraceutical and Supplement Products: Dietary supplements and nutraceutical products including vitamins and herbal supplements for immune system support
- Pharmaceutical Products: Modern herbal medicine and pharmaceutical products with BPOM authorization
- Extracted Ingredients: Plant extracts used in food, beverage, pharmaceutical, nutraceutical, cosmetics, and farming products
Go-to-market motion1 record
Distribution channels6 records
Marketing channels6 records
Sido Muncul PT product offering
Product offeringCore offering
Sido Muncul manufactures and markets herbal medicinal products (jamu), dietary supplements, and traditional health beverages using standardized Indonesian herbal formulations. Its flagship ready-to-drink product Tolak Angin and other brands such as Kunyit Asem and Kuku Bima are produced at its GMP-certified facility and sold in sachet, tablet, capsule, and syrup formats to mass-market Indonesian consumers through retail, modern trade, and pharmacy channels.
Product overview
PT Industri Jamu Dan Farmasi Sido Muncul Tbk is Indonesia's largest herbal medicine manufacturer with over 70 years of experience since 1951. The company operates multiple production facilities including extraction, modern herbal medicine, traditional jamu, powdered drinks, ready-to-drink beverages, supplements, and pharmaceutical production. The product portfolio centers on herbal remedies and wellness beverages featuring natural ingredients such as turmeric, ginger, ginseng, and honey. Core products include Tolak Angin (herbal remedy), KukuBima Ener-G! C1000 (energy drink with vitamins), Sido Muncul C-1000 (vitamin supplement), Sari Kunyit Soft Capsule (turmeric supplement), Susu Jahe (ginger milk), Kopi Jahe (ginger coffee), along with newer launches including Tolak Angin Batuk, Tentrem White Coffee, and Alang Sari Cool RTD beverages. All products hold BPOM distribution permits and MUI halal certification.
Differentiator
Problem solved
Functional benefit
Brands
- Tolak Angin: Standardised herbal remedy for cold/fever symptoms (masuk angin) formulated in 1930, containing ginger, mint, fennel, screw tree, clove leaves, and honey.
- KukuBima Ener-G!
- Kopi Jahe Sido Muncul
- Sido Muncul C-1000
- Sari Kunyit
- Tolak Linu
Products and services
- Tolak Angin Ready-to-drink herbal jamu product in liquid and tablet formats used by Indonesian consumers for relief of fatigue, colds, and travel sickness; sold in sachet and bottled forms through retail and modern trade.
- Kunyit Asem Ready-to-drink herbal beverage combining turmeric (kunyit) and tamarind (asem) marketed for digestive wellness, acidity relief, and refreshment; sold in sachet and bottled formats.
- Kuku Bima Herbal energy and vitality tonic marketed to adult men for stamina and wellness; sold in liquid format through traditional and modern trade.
- Sido Muncul Herbal Supplements Range of packaged herbal dietary supplements in tablet, capsule, and syrup forms addressing wellness needs such as immunity, liver health, uric acid, and joint support.
Quantifiable outcome
- 100 million sachets monthly production capacity
- +3 more outcomes
Companies that use Sido Muncul PT
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
Sido Muncul PT technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Sido Muncul PT partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- PT Atri DistribusindocoreSub-distributor agreement signed between PT Muncul Mekar (subsidiary of PT Industri Jamu Dan Farmasi Sido Muncul) and PT Atri Distribusindo for product distribution
- Smile Train IndonesiaminorCSR partnership for cleft lip surgery program, providing 50 free surgeries in Surabaya
- Kridoyuono Farmers GroupcoreCardamom supplier partnership in Desa Sambirata with 275 members, supplied 15 tons of cardamom over 12 shipments; includes price guarantees and agricultural technical assistance
- KTNA (National Outstanding Farmers and Fishermen's Association) ChaptersminorPartnership for Rice Inspiration Village (DIPA) program in Kabupaten Sukoharjo for balanced fertilization and organic farming
- Village Administrations (Desa Bergas Kidul, Desa Diwak, Desa Ngempon, Desa Karangjati, Desa Klepu)minorRing 1 village CSR partnerships for community development including fruit village tours, avocado and durian cultivation programs
- Perdami (Indonesian Ophthalmologists Association)coreMedical expertise partner for Free Cataract Surgery program since 2011, providing specialized ophthalmological services for underprivileged patients across Indonesia
- 242 Hospitals and Eye CentrescorePartnership network of hospitals and eye clinics across Indonesia providing operating rooms and facilities for free cataract surgery program
Scale indicators8 records
Recent moves9 records
Expansion highlights5 records
Sido Muncul PT competitors and assessment
Company assessmentBroad incumbents
- Dabur India: India's largest Ayurvedic and natural health products company with herbal supplements, juices, and OTC remedies; comparable in standardized botanical extracts, traditional-medicine heritage branding, and South-Asian consumer health market positioning.
- Himalaya Drug Company: Global herbal pharmaceutical and personal care company with a portfolio of standardized botanical medicines, OTC supplements, and wellness products; closely aligned to Sido Muncul's positioning of clinically evidenced herbal formulations for mass-market consumers.
- Blackmores Limited: Australia-listed vitamins, supplements, and herbal health products company; comparable as a publicly listed regional player in standardized herbal and nutritional supplements with established brand equity across Asia-Pacific.
- Bayer Consumer Health (Indonesia): Bayer's consumer health division markets OTC herbal and nutritional brands (e.g., Redoxon, Berocca) in Indonesia; competes with Sido Muncul in vitamin C and immune-support positioning and represents a multinational incumbent in the same shelf space.
- PT Industri Jamu dan Farmasi Sidomuncul competitors within Dexa Group: Dexa Group is an Indonesian pharmaceutical group with branded herbal and OTC consumer health products (e.g., Stimuno, HerbaKOF); competes with Sido Muncul in standardized herbal medicine and immune-support supplements in Indonesian pharmacy and retail channels.
Direct peers
- PT Kalbe Farma Tbk: Indonesia's largest pharmaceutical company with a substantial consumer health and herbal supplement division (including brands like Hydro Coco and Extra Joss); competes directly with Sido Muncul in herbal/RTD wellness beverages and over-the-counter consumer health.
- PT Soho Global Health: Indonesian pharmaceutical and herbal medicine company producing standardized herbal extracts, traditional jamu, and modern supplements; closely comparable in product format, BPOM-registered positioning, and Indonesian mass-market distribution.
- Deltomed Laboratories: Indonesian herbal medicine and traditional jamu manufacturer with overlapping product categories in herbal remedies, supplements, and consumer health beverages; comparable mass-market distribution through traditional retail and modern trade in Indonesia.
- PT Kimia Farma Tbk: State-owned Indonesian pharmaceutical manufacturer and distributor with a herbal and consumer health portfolio (including branded jamu); overlaps with Sido Muncul in BPOM-regulated herbal medicine, supplements, and pharmacy-channel distribution.
Emerging players
- Herbalife Nutrition: Global nutrition and meal-replacement supplement company with a botanical/herbal product range; comparable in dietary supplements and wellness beverages, though distributed through MLM rather than traditional retail, limiting direct channel overlap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Sido Muncul PT social profiles
Digital presenceSido Muncul PT compliance and trust
Trust signalCompliance5 records
Sido Muncul PT financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sido Muncul PT leadership team
Management profileNumber of profiles
Profiles2 records
Sido Muncul PT subsidiaries and ownership
Company hierarchySubsidiaries4 records
Sido Muncul PT funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sido Muncul PT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sido Muncul PT
What does Sido Muncul PT do?
Sido Muncul manufactures and markets herbal medicinal products (jamu), dietary supplements, and traditional health beverages using standardized Indonesian herbal formulations. Its flagship ready-to-drink product Tolak Angin and other brands such as Kunyit Asem and Kuku Bima are produced at its GMP-certified facility and sold in sachet, tablet, capsule, and syrup formats to mass-market Indonesian consumers through retail, modern trade, and pharmacy channels.
Is Sido Muncul PT a public or private company?
Sido Muncul PT is a public company. It is classified as public and is currently operating.
When was Sido Muncul PT founded?
Sido Muncul PT was founded in 1951. It employs 1,001 to 5,000 people.
Where is Sido Muncul PT based?
Sido Muncul PT is headquartered in Semarang, Indonesia, in the Asia region.
How does Sido Muncul PT make money?
Five revenue lines are on record. Herbal Medicine Products are the primary driver. The others are beverage Products, nutraceutical and Supplement Products, pharmaceutical Products and extracted Ingredients.
Who are Sido Muncul PT's main competitors?
Broad incumbents on record are Dabur India, Himalaya Drug Company, Blackmores Limited, Bayer Consumer Health (Indonesia) and PT Industri Jamu dan Farmasi Sidomuncul competitors within Dexa Group. Direct peers are PT Kalbe Farma Tbk, PT Soho Global Health, Deltomed Laboratories and PT Kimia Farma Tbk. Herbalife Nutrition is listed as an emerging player.
Does Sido Muncul PT have an API?
No public API is recorded for Sido Muncul PT.
What industry is Sido Muncul PT in?
Sido Muncul PT's product category is Herbal Pharmaceuticals. Its primary akta.pro industry code is CRADAGAD, Herbal & Botanical Supplements, with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 312111 and its SIC code is 2833.